In-line hemofiltration minimized extracorporeal membrane oxygenation-related inflammation in a porcine model

Perfusion (United Kingdom)

Volumn 29, Issue 6, 2014, Pages 526-533

  Jialiang, S ^a   Juanhong, S ^a   Qiyi, C ^a   Wenkui, Y ^a   Changsheng, H ^a   Yimin, H ^a   Juanjuan, Z ^a   Tao, G ^a   Fengchan, X ^a   Jieshou, L ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

C reactive protein; cytokines; extracorporeal membrane oxygenation; hemofiltration; systemic inflammatory response

Indexed keywords

C REACTIVE PROTEIN; HEPARIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE;

ANIMAL EXPERIMENT; ARTICLE; CANNULATION; CONTINUOUS HEMOFILTRATION; CONTINUOUS RENAL REPLACEMENT THERAPY; CONTROLLED STUDY; EXTRACORPOREAL MEMBRANE OXYGENATION DEVICE; EXTRACORPOREAL OXYGENATION; GAS EXCHANGE; HEMODYNAMICS; HEMOFILTRATION APPARATUS; INFLAMMATION; MEDICAL DEVICE; NONHUMAN; PORCINE MODEL; PROTEIN BLOOD LEVEL; ADVERSE EFFECTS; ANIMAL; BLOOD; DISEASE MODEL; FEMALE; HEMODIAFILTRATION; MALE; PIG; PROCEDURES; TIME;

ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; HEMODIAFILTRATION; INFLAMMATION; MALE; SWINE; TIME FACTORS;

EID: 84912047844     PISSN: 02676591     EISSN: 1477111X     Source Type: Journal    
DOI: 10.1177/0267659114529320     Document Type: Article

References (31)

1. Noah MA, Peek GJ, Finney SJ, et al. Referral to an extracorporeal membrane oxygenation center and mortality among patients with severe 2009 influenza A(H1N1). JAMA. 2011 ; 306: 1659-1668
2. Peek GJ, Mugford M, Tiruvoipati R, et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet. 2009 ; 374: 1351-1363
3. Beiderlinden M, Eikermann M, Boes T, et al. Treatment of severe acute respiratory distress syndrome: role of extracorporeal gas exchange. Intensive Care Med. 2006 ; 32: 1627-1631
4. Mols G, Loop T, Geiger K, et al. Extracorporeal membrane oxygenation: a ten-year experience. Am J Surg. 2000 ; 180: 144-154
5. Park PK, Napolitano LM, Bartlett RH. Extracorporeal membrane oxygenation in adult acute respiratory distress syndrome. Crit Care Clin. 2011 ; 27: 627-646
6. Zangrillo A, Landoni G, Biondi-Zoccai G, et al. A meta-analysis of complications and mortality of extracorporeal membrane oxygenation. Crit Care Resusc. 2013 ; 15: 172-178
7. Repesse X, Au SM, Brechot N, et al. Recombinant factor VIIa for uncontrollable bleeding in patients with extracorporeal membrane oxygenation: report on 15 cases and literature review. Crit Care. 2013 ; 17: R55
8. Toomasian JM, Bartlett RH. Hemolysis and ECMO pumps in the 21st Century. Perfusion. 2011 ; 26: 5-6
9. Kossel H, Bartsch H, Philippi W, et al. Pulmonary embolism and myocardial hypoxia during extracorporeal membrane oxygenation. J Pediatr Surg. 1999 ; 34: 485-487
10. Sun HY, Ko WJ, Tsai PR, et al. Infections occurring during extracorporeal membrane oxygenation use in adult patients. J Thorac Cardiovasc Surg. 2010 ; 140: 1125-1132
11. Brogan TV, Thiagarajan RR, Rycus PT, et al. Extracorporeal membrane oxygenation in adults with severe respiratory failure: a multi-center database. Intensive Care Med. 2009 ; 35: 2105-2114
12. Meliones JN, Moler FW, Custer JR, et al. Hemodynamic instability after the initiation of extracorporeal membrane oxygenation: role of ionized calcium. Crit Care Med. 1991 ; 19: 1247-1251
13. Kelly RE, Phillips JD, Foglia RP, et al. Pulmonary edema and fluid mobilization as determinants of the duration of ECMO support. J Pediatr Surg. 1991 ; 26: 1016-1022
14. Mc Ilwain RB, Timpa JG, Kurundkar AR, et al. Plasma concentrations of inflammatory cytokines rise rapidly during ECMO-related SIRS due to the release of preformed stores in the intestine. Lab Invest. 2010 ; 90: 128-139
15. Song J, Palmer K, Sun B. Effects of inhaled nitric oxide and surfactant with extracorporeal life support in recovery phase of septic acute lung injury in piglets. Pulm Pharmacol Ther. 2010 ; 23: 78-87
16. Fortenberry JD, Bhardwaj V, Niemer P, et al. Neutrophil and cytokine activation with neonatal extracorporeal membrane oxygenation. J Pediatr. 1996 ; 128: 670-678
17. Mildner RJ, Taub N, Vyas JR, et al. Cytokine imbalance in infants receiving extracorporeal membrane oxygenation for respiratory failure. Biol Neonate. 2005 ; 88: 321-327
18. Graulich J, Walzog B, Marcinkowski M, et al. Leukocyte and endothelial activation in a laboratory model of extracorporeal membrane oxygenation (ECMO). Pediatr Res. 2000 ; 48: 679-684
19. DePuydt LE, Schuit KE, Smith SD. Effect of extracorporeal membrane oxygenation on neutrophil function in neonates. Crit Care Med. 1993 ; 21: 1324-1327
20. Underwood MJ, Pearson JA, Waggoner J, et al. Changes in "inflammatory" mediators and total body water during extra-corporeal membrane oxygenation (ECMO). A preliminary study. Int J Artif Organs. 1995 ; 18: 627-632
21. Paden ML, Warshaw BL, Heard ML, et al. Recovery of renal function and survival after continuous renal replacement therapy during extracorporeal membrane oxygenation. Pediatr Crit Care Med. 2011 ; 12: 153-158
22. De Vriese AS, Vanholder RC, Pascual M, et al. Can inflammatory cytokines be removed efficiently by continuous renal replacement therapies?. Intensive Care Med. 1999 ; 25: 903-910
23. Tsai TY, Tsai FC, Chang CH, et al. Prognosis of patients on extracorporeal membrane oxygenation plus continuous arteriovenous hemofiltration. Chang Gung Med J. 2011 ; 34: 636-643
24. Santiago MJ, Sanchez A, Lopez-Herce J, et al. The use of continuous renal replacement therapy in series with extracorporeal membrane oxygenation. Kidney Int. 2009 ; 76: 1289-1292
25. Yu K, Long C, Hei F, et al. Clinical evaluation of two different extracorporeal membrane oxygenation systems: a single center report. Artif Organs. 2011 ; 35: 733-737
26. Sievert AN, Shackelford AG, McCall MM. Trends and emerging technologies in extracorporeal life support: results of the 2006 ECLS survey. J Extra Corpor Technol. 2009 ; 41: 73-78
27. Blumberg N. Allogeneic transfusion and infection: economic and clinical implications. Semin Hematol. 1997 ; 34: 34-40
28. Heering P, Morgera S, Schmitz FJ, et al. Cytokine removal and cardiovascular hemodynamics in septic patients with continuous venovenous hemofiltration. Intensive Care Med. 1997 ; 23: 288-296
29. De Vriese AS, Colardyn FA, Philippe JJ, et al. Cytokine removal during continuous hemofiltration in septic patients. J Am Soc Nephrol. 1999 ; 10: 846-853
30. Li W, Yan X, Wang H, et al. Effects of continuous high-volume hemofiltration on experimental severe acute pancreatitis in pigs. Pancreas. 2007 ; 34: 112-119
31. Yimin H, Wenkui Y, Jialiang S, et al. Effects of continuous renal replacement therapy on renal inflammatory cytokines during extracorporeal membrane oxygenation in a porcine model. J Cardiothorac Surg. 2013 ; 8: 113